ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

22,330Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 38

$1.04M Total Retail Price of All Prescriptions

Rank: 5 out of 38

535 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
88% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

32% of this provider’s 535 patients filled at least one prescription for a schedule two drug, compared to an average of 14%.

Schedule Three
Controlled Substances

27% of this provider’s 535 patients filled at least one prescription for a schedule three drug, compared to an average of 25%.

Risky Drugs to Seniors

1% of this provider’s 21,145 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

42 is the average number of prescriptions (including refills) per patient, compared to an average of 31.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
WARFARIN SODIUM 1,035 983 1 7
OMEPRAZOLE 904 877 2 6
LEVOTHYROXINE SODIUM 903 839 3 2
CITALOPRAM HBR 824 807 4 12
LISINOPRIL 793 776 5 4
FUROSEMIDE 742 719 6 3
FENTANYL 682 654 S2 7 14
DONEPEZIL HCL 646 633 8 10
HYDROCODONE-ACETAMINOPHEN 628 596 S3 9 1
SERTRALINE HCL 586 577 10 16
SIMVASTATIN 567 522 11 5
MIRTAZAPINE 496 474 12 17
METOPROLOL SUCCINATE 455 442 13 21
TRAZODONE HCL 431 428 14 29
METOPROLOL TARTRATE 422 410 15 8
TRAMADOL HCL 396 361 16 19
CYMBALTA 375 366 17 38
NAMENDA 371 364 18 13
POTASSIUM CHLORIDE 345 342 19 11
AMLODIPINE BESYLATE 320 320 20 9
POLYETHYLENE GLYCOL 3350 304 292 21 15
KLOR-CON 10 279 254 22 103
RANITIDINE HCL 253 253 23 24
RISPERIDONE 250 237 24 26
GABAPENTIN 229 203 25 18
ATENOLOL 219 219 26 22
DIVALPROEX SODIUM 207 192 27 28
LANTUS 179 155 28 20
NOVOLIN N 177 173 29 116
CARBIDOPA-LEVODOPA 173 173 30 32
CARVEDILOL 170 170 31 27
QUETIAPINE FUMARATE 166 165 32 33
NYSTOP 162 160 33 68
PAROXETINE HCL 158 113 34 48
VENLAFAXINE HCL ER 144 100 35 75
MORPHINE SULFATE 140 127 S2 36 79
ESCITALOPRAM OXALATE 140 129 36 40
TAMSULOSIN HCL 140 126 36 31
GLIPIZIDE 138 137 39 52
BUSPIRONE HCL 128 128 40 100
ALENDRONATE SODIUM 128 127 40 45
LIDODERM 126 126 42 71
TRIAMCINOLONE ACETONIDE 125 122 43 89
HYDROCHLOROTHIAZIDE 124 117 44 25
CLOPIDOGREL 118 118 45 34
METFORMIN HCL 109 89 46 23
NYSTATIN 107 103 47 43
SPIRIVA 105 98 48 65
LOSARTAN POTASSIUM 102 102 49 47
OXYBUTYNIN CHLORIDE ER 100 86 50 57
DIGOXIN 98 98 51 46
KETOCONAZOLE 96 72 52 166
BACLOFEN 93 39 53 77
FLUTICASONE PROPIONATE 93 88 53 73
ADVAIR DISKUS 89 86 55 54
BUMETANIDE 89 89 55 49
ALBUTEROL SULFATE 87 86 57 44
PLAVIX 87 87 57 51
LATANOPROST 83 83 59 110
FAMOTIDINE 82 82 60 35
SPIRONOLACTONE 82 72 60 58
AGGRENOX 80 80 62 174
PREDNISONE 77 58 63 41
CEPHALEXIN 75 71 64 55
DILTIAZEM 24HR CD 73 63 65 90
ROPINIROLE HCL 71 70 66 98
DOXYCYCLINE HYCLATE 70 68 67 112
ISOSORBIDE MONONITRATE ER 64 64 68 30
HYDRALAZINE HCL 62 62 69 62
ATORVASTATIN CALCIUM 58 53 70 37
IPRATROPIUM BROMIDE 58 50 70 92
NORTRIPTYLINE HCL 57 57 72 145
SEROQUEL 56 56 73 91
SOTALOL 55 55 74 200
FINASTERIDE 54 50 75 134
OXYCODONE HCL 54 43 S2 75 36
METHENAMINE HIPPURATE 53 53 77 205
KLOR-CON M20 52 52 78 42
FLUOXETINE HCL 50 45 79 106
OLANZAPINE 50 37 79 70
BUPROPION HCL SR 50 48 79 163
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.